Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Liver.

Víctor M Piñeiro-Carrero1, Eric O Piñeiro

  • 1Alfred I. duPont Hospital for Children, Wilmington, Delaware 19899, USA. vpineiro@nemours.org

Pediatrics
|April 3, 2004
PubMed
Summary
This summary is machine-generated.

Pediatric liver toxicity from drugs and environmental toxins varies with age due to developmental changes in metabolism. Understanding these differences is key to diagnosing and managing hepatotoxicity in children.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

From Screening to Support: Crafting Social Needs Response Systems That Work for Families.

Pediatrics·2026
Same journal

A Social Care Intervention in Pediatric Practices: A Stepped Wedge Cluster Trial.

Pediatrics·2026
Same journal

Pediatric Cheerleading-Related Head Injuries and the "Double Down" Rule Change.

Pediatrics·2026
Same journal

Tobacco Use Among Middle and High School Students: 2025 National Youth Tobacco Survey.

Pediatrics·2026
Same journal

Nirmatrelvir/Ritonavir for the Treatment of COVID-19 in Children Aged 6 Years and Older.

Pediatrics·2026
Same journal

Correction to "Standardized Criteria for Genomic Testing in the NICU".

Pediatrics·2026
See all related articles

Area of Science:

  • Hepatology
  • Pediatric Toxicology
  • Pharmacology

Background:

  • The liver is a primary target for drug and xenobiotic toxicity due to its metabolic functions.
  • Pediatric populations exhibit varied sensitivity to toxins, influenced by developmental changes in liver metabolism from birth to adolescence.

Purpose of the Study:

  • To explore the impact of developmental changes in hepatic metabolism on pediatric drug toxicity.
  • To elucidate age-related differences in susceptibility and resistance to specific hepatotoxins in children.

Main Methods:

  • Review of existing literature on pediatric hepatotoxicity, drug metabolism, and xenobiotic interactions.
  • Analysis of age-specific metabolic pathways, including glucuronidation, sulfation, and glutathione synthesis.

Related Experiment Videos

Main Results:

  • Neonatal livers have reduced capacity for xenobiotic metabolism and excretion, leading to prolonged drug action and increased risk of syndromes like gray infant syndrome.
  • Children show differential susceptibility: resistance to acetaminophen hepatotoxicity (due to sulfation predominance and higher glutathione synthesis) versus increased susceptibility to valproic acid toxicity.
  • Drug-induced liver injury (hepatotoxicity) can manifest as various liver pathologies, with hepatitis being most common, often requiring exclusion of other causes for diagnosis.

Conclusions:

  • Age-related metabolic differences significantly influence pediatric drug and xenobiotic toxicity.
  • Prompt identification of exposure and discontinuation of the offending agent are crucial for managing drug-induced liver injury in children.
  • Liver transplantation may be required in cases of severe, unresolved liver failure due to toxicity.